1. HCQ works *early*; this study was within 24-48 hours of hospital admissions.
— Phil Kerpen (@kerpen) July 3, 2020
The members of the lying mainstream media are truly the enemy of the people. For months these despicable propagandists denounced and mocked the POTUS for endorsing Hydroxychloroquine. The MSM told us that Hydroxychloroquine is deadly, and insisted that Trump has a financial interest in the company that produces this drug. Like the Democrat Party, the MSM has an interest in keeping America shut down. That is because President Trump has a much better chance of being re-elected in November if America is open. An America that has a roaring economy. Don’t expect these thugs in suits to apologize for their latest act of negligence and malfeasance.
Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds
Detroit News, July 3, 2020:
A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday.
Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis.
The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and May 2 and found 13% of those treated with hydroxychloroquine died while 26% of those who did not receive the drug died.
Among all patients in the study, there was an overall in-hospital mortality rate of 18%, and many who died had underlying conditions that put them at greater risk, according to Henry Ford Health System. Globally, the mortality rate for hospitalized patients is between 10% and 30%, and it’s 58% among those in the intensive care unit or on a ventilator.
Study finds hydroxychloroquine helped coronavirus patients survive better
By CNN, July 3, 2020
A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital.A team at Henry Ford Health System in Southeast Michigan said Thursday its study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die.Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said 26% of those not given hydroxychloroquine died, compared to 13% of those who got the drug. The team looked back at everyone treated in the hospital system since the first patient in March.“Overall crude mortality rates were 18.1% in the entire cohort, 13.5% in the hydroxychloroquine alone group, 20.1% among those receiving hydroxychloroquine plus azithromycin, 22.4% among the azithromycin alone group, and 26.4% for neither drug,” the team wrote in a report published in the International Journal of Infectious Diseases.It’s a surprising finding because several other studies have found no benefit from hydroxychloroquine, a drug originally developed to treat and prevent malaria. President Donald Trump touted the drug heavily, but later studies found not only did patients not do better if they got the drug, they were more likely to suffer cardiac side effects.The US Food and Drug Administration withdrew its emergency use authorization for the drug earlier this month and trials around the world, including trials sponsored by the World Health Organization and the National Institutes of Health, were halted.“Our results do differ from some other studies,” Zervos told a news conference. “What we think was important in ours … is that patients were treated early. For hydroxychloroquine to have a benefit, it needs to begin before the patients begin to suffer some of the severe immune reactions that patients can have with Covid,” he added.
he Henry Ford team also monitored patients carefully for heart problems, he said.“The combination of hydroxychloroquine plus azithromycin was reserved for selected patients with severe COVID-19 and with minimal cardiac risk factors,” the team wrote.The Henry Ford team said they believe their findings show hydroxychloroquine could be potentially useful as a treatment for coronavirus.“It’s important to note that in the right settings, this potentially could be a lifesaver for patients,” Dr. Steven Kalkanis, CEO of the Henry Ford Medical Group, said at the news conference.
Have a tip we should know? Your anonymity is NEVER compromised. Email email@example.com
The Truth Must be Told
Your contribution supports independent journalism
Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.
Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.
Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.
Please contribute here.
Make a monthly commitment to support The Geller Report – choose the option that suits you best.